A 2018 review of 16 research of cannabis-dependent medicines for neuropathic pain, the majority of which tested a cannabinoid preparing named nabiximols (brand identify Sativex; a mouth spray made up of each THC and CBD which is authorised in certain nations around the world but not in the United States), identified low- to moderate-high quality pr